Contact us

Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge

View
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge
View
IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies
View
Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products
View
Novel application of synchrotron x-ray computed tomography for ex-vivo imaging of subcutaneously injected polymeric microsphere suspension formulations
View
Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin
View
The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib
View
Nonclinical safety and pharmacokinetics of Miglyol 812: A medium chain triglyceride in exenatide once weekly suspension
View
The effect of food or omeprazole on the pharmacokinetics of osimertinib in patients with non-small cell lung cancer and in healthy volunteers
View
Emerging trends in therapeutic algorithm of chronic wound healers: Recent advances in drug delivery systems, concepts-to-clinical application, and future prospects
View
The impact of formulation attributes and process parameters on black seed oil loaded liposomes and their performance in animal models of analgesia
View
Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid
View
Clinical pharmacology profile of an oral selective androgen receptor down-regulator, AZD3514: Implications on the design of ongoing castrate-resistant prostate cancer clinical studies